These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21134342)

  • 1. Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome.
    Li B; Zhang LH; Yang XG; Liu XT; Ren YG
    Clin Invest Med; 2010 Dec; 33(6):E398-404. PubMed ID: 21134342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease.
    Zhao ZW; Zhu XL; Luo YK; Lin CG; Chen LL
    Clin Cardiol; 2011 Mar; 34(3):172-7. PubMed ID: 21400544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease.
    Kott KA; Genetzakis E; Gray MP; Hansen P; McGuire HM; Yang JY; Grieve SM; Vernon ST; Figtree GA
    Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Yi T; Chen LL
    Biochem Med (Zagreb); 2019 Feb; 29(1):010705. PubMed ID: 30799974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.
    Dey AK; Gaddipati R; Elnabawi YA; Ongstad E; Goyal A; Chung JH; Teague HL; Rodante JA; Sajja AA; Sorokin AV; Lateef SS; Aksentijevich M; Choi H; Reddy AS; Varghese NJ; Groenendyk J; Belur AD; Genovese L; Rivers JP; Lerman J; Kabbany MT; Harrington C; Ortiz J; Khalil N; Keel A; Baumer Y; Chen MY; Bluemke DA; Joshi AA; Kaplan MJ; Remaley AT; Playford MP; Karathanasis SK; Gelfand JM; Gupta R; Mehta NN
    JAMA Dermatol; 2020 Feb; 156(2):151-157. PubMed ID: 31746956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with erectile dysfunction in patients without known coronary artery disease.
    Kobat MA; Fırdolas F; Balin M; Çelik A; Bentli R; Baydas A
    J Sex Med; 2013 Nov; 10(11):2782-9. PubMed ID: 23088332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis.
    Florida EM; Li H; Hong CG; Ongstad EL; Gaddipati R; Sitaula S; Varma V; Parel PM; O'Hagan R; Chen MY; Teague HL; Playford MP; Karathanasis SK; Collén A; Mehta NN; Remaley AT; Sorokin AV
    J Am Heart Assoc; 2023 Nov; 12(22):e031227. PubMed ID: 37982276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.
    Hayashida K; Kume N; Murase T; Minami M; Nakagawa D; Inada T; Tanaka M; Ueda A; Kominami G; Kambara H; Kimura T; Kita T
    Circulation; 2005 Aug; 112(6):812-8. PubMed ID: 16061745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Sun JM; Hong JC; Chen LL
    Dis Markers; 2019; 2019():4925767. PubMed ID: 31772687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel biomarker for large-artery atherosclerotic stroke.
    Huang W; Li Q; Chen X; Lin Y; Xue J; Cai Z; Zhang W; Wang H; Jin K; Shao B
    Int J Neurosci; 2017 Oct; 127(10):881-886. PubMed ID: 27967338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
    Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
    Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease.
    Kamezaki F; Yamashita K; Tasaki H; Kume N; Mitsuoka H; Kita T; Adachi T; Otsuji Y
    Int J Cardiol; 2009 May; 134(2):285-7. PubMed ID: 18367271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases.
    Pirillo A; Catapano AL
    Dis Markers; 2013; 35(5):413-8. PubMed ID: 24198442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome.
    Dong B; Ji W; Zhang Y
    Intern Med; 2011; 50(10):1093-7. PubMed ID: 21576834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers.
    Lubrano V; Del Turco S; Nicolini G; Di Cecco P; Basta G
    Lipids; 2008 Oct; 43(10):945-50. PubMed ID: 18781352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome.
    Kumar S; Ali W; Mishra S; Pradhan A; Sethi R; Kushwaha R; Singh US; Perrone MA
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study.
    Yokota C; Sawamura T; Watanabe M; Kokubo Y; Fujita Y; Kakino A; Nakai M; Toyoda K; Miyamoto Y; Minematsu K
    J Atheroscler Thromb; 2016 Oct; 23(10):1222-1226. PubMed ID: 27025681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population.
    Yoon SE; Ahn SG; Kim JY; Park JS; Shin JH; Tahk SJ; Lee SK; Kim TJ; Han N
    J Korean Med Sci; 2011 Jul; 26(7):900-5. PubMed ID: 21738343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of sLOX-1 Level in Acute Coronary Syndromes Based on Thrombolysis in Myocardial Infarction Risk Score and Clinical Outcome.
    Mashayekhi S; Ziaee M; Garjani A; Sarbakhsh P; Ghaffari S
    J Emerg Med; 2018 Sep; 55(3):390-398. PubMed ID: 30049431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.